S
GNOM icon

SignatureFD’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

SignatureFD’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50
Closed -$4K – 2605
2020
Q3 		$4K Buy
+50
New +$3.58K ﹤0.01% 1968

Other funds holding GNOM

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

SignatureFD's GNOM Position: Q4 2020 in Review

SignatureFD sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2020, closing a stake of 50 shares — an estimated $4K sold.

SignatureFD first reported a position in GNOM in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 26 funds tracked by Wall St. Rank hold GNOM as of Q4 2020.

  • SignatureFD reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
  • SignatureFD sold 50 Global X Genomics & Biotechnology ETF shares in Q4 2020, an estimated $4K.
  • SignatureFD first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and held it in 1 quarter.
  • SignatureFD's Global X Genomics & Biotechnology ETF position peaked at $4K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2020.

Based on SignatureFD's 13F filing for Q4 2020, filed 11 Feb 2021.